Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7819003rdf:typepubmed:Citationlld:pubmed
pubmed-article:7819003lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:7819003lifeskim:mentionsumls-concept:C2700615lld:lifeskim
pubmed-article:7819003lifeskim:mentionsumls-concept:C0020538lld:lifeskim
pubmed-article:7819003lifeskim:mentionsumls-concept:C0425358lld:lifeskim
pubmed-article:7819003lifeskim:mentionsumls-concept:C0022671lld:lifeskim
pubmed-article:7819003lifeskim:mentionsumls-concept:C0596382lld:lifeskim
pubmed-article:7819003lifeskim:mentionsumls-concept:C0684224lld:lifeskim
pubmed-article:7819003lifeskim:mentionsumls-concept:C0022646lld:lifeskim
pubmed-article:7819003lifeskim:mentionsumls-concept:C0687676lld:lifeskim
pubmed-article:7819003lifeskim:mentionsumls-concept:C1521725lld:lifeskim
pubmed-article:7819003lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:7819003pubmed:issue5lld:pubmed
pubmed-article:7819003pubmed:dateCreated1995-2-16lld:pubmed
pubmed-article:7819003pubmed:abstractTextHypertension is common in children after renal transplantation and is associated with multiple factors. Data regarding the prevalence of post-transplant hypertension and the relationship between immunosuppressive drugs and the persistence of hypertension in a large population of North American children have not been available. This study was designed by the North American Pediatric Renal Transplant Cooperative Study to evaluate in a large diverse multicenter population of children the prevalence of hypertension post transplantation, the type of antihypertensive medications used to treat this hypertension and to determine the relationship between the blood pressure control and the immunosuppressive therapy. Analysis of 277 patients showed the following: (1) 70% of recipients required antihypertensive medications 1 month post transplant compared with 48% pre transplant; the incidence decreased to 59% at 24 months; (2) the majority of children received multiple drug therapy to control blood pressure; (3) hypertension can be controlled effectively despite inherent etiological factors, such as allograft source, prior hypertension and immunosuppressive therapy.lld:pubmed
pubmed-article:7819003pubmed:languageenglld:pubmed
pubmed-article:7819003pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7819003pubmed:citationSubsetIMlld:pubmed
pubmed-article:7819003pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7819003pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7819003pubmed:statusMEDLINElld:pubmed
pubmed-article:7819003pubmed:monthOctlld:pubmed
pubmed-article:7819003pubmed:issn0931-041Xlld:pubmed
pubmed-article:7819003pubmed:authorpubmed-author:GruskinA BABlld:pubmed
pubmed-article:7819003pubmed:authorpubmed-author:IngelfingerJ...lld:pubmed
pubmed-article:7819003pubmed:authorpubmed-author:TejaniAAlld:pubmed
pubmed-article:7819003pubmed:authorpubmed-author:StableinDDlld:pubmed
pubmed-article:7819003pubmed:authorpubmed-author:BaluarteH JHJlld:pubmed
pubmed-article:7819003pubmed:issnTypePrintlld:pubmed
pubmed-article:7819003pubmed:volume8lld:pubmed
pubmed-article:7819003pubmed:ownerNLMlld:pubmed
pubmed-article:7819003pubmed:authorsCompleteYlld:pubmed
pubmed-article:7819003pubmed:pagination570-3lld:pubmed
pubmed-article:7819003pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:7819003pubmed:meshHeadingpubmed-meshheading:7819003-...lld:pubmed
pubmed-article:7819003pubmed:meshHeadingpubmed-meshheading:7819003-...lld:pubmed
pubmed-article:7819003pubmed:meshHeadingpubmed-meshheading:7819003-...lld:pubmed
pubmed-article:7819003pubmed:meshHeadingpubmed-meshheading:7819003-...lld:pubmed
pubmed-article:7819003pubmed:meshHeadingpubmed-meshheading:7819003-...lld:pubmed
pubmed-article:7819003pubmed:meshHeadingpubmed-meshheading:7819003-...lld:pubmed
pubmed-article:7819003pubmed:meshHeadingpubmed-meshheading:7819003-...lld:pubmed
pubmed-article:7819003pubmed:meshHeadingpubmed-meshheading:7819003-...lld:pubmed
pubmed-article:7819003pubmed:meshHeadingpubmed-meshheading:7819003-...lld:pubmed
pubmed-article:7819003pubmed:meshHeadingpubmed-meshheading:7819003-...lld:pubmed
pubmed-article:7819003pubmed:meshHeadingpubmed-meshheading:7819003-...lld:pubmed
pubmed-article:7819003pubmed:meshHeadingpubmed-meshheading:7819003-...lld:pubmed
pubmed-article:7819003pubmed:year1994lld:pubmed
pubmed-article:7819003pubmed:articleTitleAnalysis of hypertension in children post renal transplantation--a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).lld:pubmed
pubmed-article:7819003pubmed:affiliationSt. Christopher's Hospital for Children, Temple University School of Medicine, Philadelphia, Pennsylvania.lld:pubmed
pubmed-article:7819003pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7819003pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7819003lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7819003lld:pubmed